Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations

CCO Oncology Podcast - En podkast av Clinical Care Options

Prøv Podimo gratis i hele 60! dager!

I Podimo finner du eksklusive podkaster og bestselgende lydbøker tilpasset dine ører

In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses using targeted therapies in patients with FLT3- or IDH1/2-mutated AML.